These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15700191)

  • 1. [Early Manifest Glaucoma Trial update 2004].
    Erb C
    Ophthalmologe; 2005 Mar; 102(3):219-21. PubMed ID: 15700191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Komaroff E
    Curr Opin Ophthalmol; 2004 Apr; 15(2):102-6. PubMed ID: 15021220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
    Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
    Leske MC; Heijl A; Hussein M; Bengtsson B; Hyman L; Komaroff E;
    Arch Ophthalmol; 2003 Jan; 121(1):48-56. PubMed ID: 12523884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
    Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disc hemorrhages and treatment in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Yang Z; Heijl A;
    Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring visual field progression in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Bengtsson B; Hussein M;
    Acta Ophthalmol Scand; 2003 Jun; 81(3):286-93. PubMed ID: 12780410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.
    Heijl A; Peters D; Leske MC; Bengtsson B
    Am J Ophthalmol; 2011 Nov; 152(5):842-8. PubMed ID: 21843876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma.
    Shah R; Wormald R
    Clin Evid; 2002 Jun; (7):589-96. PubMed ID: 12230685
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined cataract and glaucoma surgery: endoscope-controlled erbium:YAG-laser goniotomy versus trabeculectomy.
    Philippin H; Wilmsmeyer S; Feltgen N; Ness T; Funk J
    Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):684-8. PubMed ID: 15688161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cataract and trabeculectomy surgery in eyes with pseudoexfoliation glaucoma.
    Shingleton BJ; Wooler KB; Bourne CI; O'Donoghue MW
    J Cataract Refract Surg; 2011 Nov; 37(11):1961-70. PubMed ID: 21907537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
    Ohtake Y; Tanino T; Kimura I; Mashima Y; Oguchi Y
    Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial.
    Katz LJ; Steinmann WC; Kabir A; Molineaux J; Wizov SS; Marcellino G;
    J Glaucoma; 2012 Sep; 21(7):460-8. PubMed ID: 21543992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery.
    Berthold S; Pfeiffer N
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):1029-34. PubMed ID: 16341541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical investigation: the intraocular pressure-lowering efficacy and safety of brinzolamide combined with betaxolol].
    Minbin Y; Fang M; Ge J; Huang S
    Yan Ke Xue Bao; 2005 Dec; 21(4):137-40, 152. PubMed ID: 17162869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.